This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September quarter revenue up 5.1%, profit after tax down 3.5%; control transferred
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On a standalone basis for the quarter ended September 30, 2026, revenue from operations rose 5.1% to Rs 2,683.42 lakh from Rs 2,553.32 lakh, while profit after tax fell 3.5% to Rs 644.03 lakh from Rs 667.63 lakh. For the standalone half year, revenue was Rs 5,522.06 lakh and profit after tax Rs 1,374.33 lakh; operating cash flow was Rs 1,604.13 lakh. Review was unmodified; Indo Borax took 64.26% control; prior figures were regrouped.
Revenue grew, but profit after tax and operating margin slipped. New owner Indo Borax may support growth, leaving the near-term outlook mixed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹55.22 Cr | ₹25.53 Cr | +116.3% |
| Operating profit | ₹16.38 Cr | ₹8.14 Cr | +101.3% |
| Profit after tax | ₹13.74 Cr | ₹6.68 Cr | +105.9% |
| EBITDA margin | 31.6% | 33.9% | −2.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.